Nice find! I think they need some more cash, but that doesn't mean they don't have a plan to get it so it's good to see them still moving forward.
Replicel
Collapse
X
-
-
I was reading ylast week of a group of male scientists being able to grow a new nose for a cancer patient - surely... if they're able to grow noses they can harness that ability into regenerating hair follicles? Can they not reproduce skin from the back of the head in the lab yet?Comment
-
I thought they started it already. Bollocks.
But at least this time they'll use more than 100 men and this IS effectiveness study. Finally. This means (probably) this time next year we'll know if they're breakthrough of a bust.
ps, the stock is up by 25%!Comment
-
Replicel Smart
A smart company stays in touch with and takes direction from the regulatory body all the way. Then there are no surprises at the finish line from the guys with the gun! Replicel are doing just that, it seems. These guys are poised to knock this out of the park in my opinion.Comment
-
I think it's good to have an update from them and to know they're still progressing. Yes they did originally plan to start phase II on autumn of last year but from what they've said it looks like they went away and changed some things and that's why the phase II is now gonna start later than they originally hoped. I'd sooner have a bit of a delay if it means they're going to progress more successfully. It's no good to us if they fly through the trials but come out of it with a sub standard product.Comment
-
RepliCel to Present at the 11th Annual BioPartnering North America Conference
February 19, 2013
Vancouver Convention Centre, Vancouver, BC, February 24-26th, 2013
VANCOUVER, BC – February 19th 2013 – RepliCel Life Sciences Inc (the “Company” or “RepliCel”) (OTCBB: REPCF) (CNSX: RP) today announced that the Company will present to a select group of biotech industry investors and experts at the 11th Annual BioPartnering North America Conference (“BPN”) in Vancouver, BC, on Monday, February 25th at 10:30am in room 121. David Hall, CEO, will give a corporate overview on RepliCel’s autologous cell replication technology and current clinical development plans.
Following the BPN conference, RepliCel is set to attend the 7th World Congress for Hair Research in Edinburgh on May 4-6th 2013. The Company looks forward to another international gathering of the global hair research societies.Comment
-
RepliCel to Present at the 11th Annual BioPartnering North America Conference
February 19, 2013
Vancouver Convention Centre, Vancouver, BC, February 24-26th, 2013
VANCOUVER, BC – February 19th 2013 – RepliCel Life Sciences Inc (the “Company” or “RepliCel”) (OTCBB: REPCF) (CNSX: RP) today announced that the Company will present to a select group of biotech industry investors and experts at the 11th Annual BioPartnering North America Conference (“BPN”) in Vancouver, BC, on Monday, February 25th at 10:30am in room 121. David Hall, CEO, will give a corporate overview on RepliCel’s autologous cell replication technology and current clinical development plans.
Following the BPN conference, RepliCel is set to attend the 7th World Congress for Hair Research in Edinburgh on May 4-6th 2013. The Company looks forward to another international gathering of the global hair research societies.
So what news will they present the 25?Comment
-
-
-
Comment
-
I'm a fan of;
1) histogen
2) aderans
3) dr gho
In my mind these guys are innocent until proven guilty.
Replicel might work but they are honestly years behind the above 3 options.
Out of all the above options I speculate dr gho could help you now except be warned that he's expensive and you're really paying for a glorified but scarless (to the human eye) FUE procedure.Comment
-
What really happened was that 2020 went crazy and bought a whole lot of shares in Replicel and a handful of people went insane.
I on the other hand who've been observing this forum for YEARS quickly spotted the hype - to be honest Replicel should be ashamed of themselves for creating such hype without the goods to back up their talk.
Histogen unlike Replicel have been in the game for a lot longer. Fingers crossed their results kick a55 this monthComment
Comment